← Back to Clinical Trials
Recruiting NCT02998788

NCT02998788 Risk Evaluation and Management in Heart Failure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02998788
Status Recruiting
Phase
Sponsor Ruijin Hospital
Condition Heart Failure
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2016-06
Primary Completion 2026-12

Trial Parameters

Condition Heart Failure
Sponsor Ruijin Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2016-06
Completion 2026-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.

Eligibility Criteria

Inclusion Criteria: * aged 18 and above * inpatient with one of the following clinical situations: * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema) * cardiogenic shock * Insufficient high output cardiac * with impaired cardiac function diagnosed by echocardiography * able to provide informed consent Exclusion Criteria: * expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology